Number of the records: 1  

skúšanie klinické ako téma

  1. SYSd002986
    LBL
      
    00000cz--a2200000n--4500
    005
      
    20250606214236.4
    008
      
    920530|||anznnbabn-----------|-a|a------
    040
      
    $b slo $a DNLM $d BA006 $d BA006 $d BA006
    065
      
    $a E05.318.372.250.250
    065
      
    $a N05.715.360.330.250.250
    065
      
    $a N06.850.520.450.250.250
    066
      
    $a 01 $c 03
    089
      
    $a 615.036 $v UDC-MRF-SK3 $z slo
    150
      
    $a skúšanie klinické ako téma $x CL $x EC $x ES $x HI $x IS $x LJ $x MT $x OG $x PX $x SN $x ST $2 slo
    450
      
    $w v $a pokusy klinické ako téma $2 slo
    450
      
    $w v $a testy klinické ako téma $2 slo
    450
      
    $w v $a skúšky klinické ako téma $2 slo
    550
      
    $7 sllk_us_auth*d002985 $Y Clinical Protocols $w b $a protokoly klinické
    550
      
    $7 sllk_us_auth*d015201 $Y Meta-Analysis as Topic $w p $a metaanalýza ako téma
    550
      
    $7 sllk_us_auth*d017277 $Y Drug Approval $w p $a registrácia lieku
    550
      
    $7 sllk_us_auth*d026661 $Y Clinical Trials Data Monitoring Committees $w p $a komisie pre monitorovanie údajov z klinického skúšania
    550
      
    $7 sllk_us_auth*d035703 $Y Therapies, Investigational $w p $a terapie investigatívne
    550
      
    $7 sllk_us_auth*d004341 $Y Drug Evaluation $w b $a hodnotenie lieku
    550
      
    $7 sllk_us_auth*d015507 $Y Drugs, Investigational $w b $a lieky skúšané
    550
      
    $7 sllk_us_auth*d026661 $Y Clinical Trials Data Monitoring Committees $w b $a komisie pre monitorovanie údajov z klinického skúšania
    550
      
    $7 sllk_us_auth*d035703 $Y Therapies, Investigational $w b $a terapie investigatívne
    665
      
    $a 2008(1965) $2 eng
    665
      
    $a Drug Evaluation (1974-1979) $2 eng
    680
    9-
    $i Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. $2 eng
    680
      
    $a for general design, methodology, economics, etc. of clinical trials; a different heading CLINICAL TRIAL is used for reports of a specific clinical trial $2 eng
    750
    -2
    $a Clinical Trials as Topic $2 eng
    980
      
    $x M
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.